Do Wall Street Analysts Like Lam Research Stock?
/Lam%20Research%20Corp_%20HQ%20sign-by%20Michael%20Vi%20via%20Shutterstock.jpg)
Lam Research Corporation (LRCX) is a global leader in semiconductor manufacturing equipment and services. With a market cap of $114.3 billion, it provides cutting-edge wafer fabrication solutions that enable the production of advanced semiconductor devices. The company’s innovative technologies and expertise support the world's leading chipmakers in delivering high-performance electronics, driving progress in computing, artificial intelligence, and mobile applications while creating long-term value for stakeholders.
Shares of the chip giant have underperformed the broader market considerably over the past year. LRCX has declined 1.1% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 23%. However, in 2025, LRCX’s stock gained 23.3%, compared to SPX’s 4% rise on a YTD basis.
Zooming in further, the Fremont, California-based company has also underperformed the Invesco Semiconductors ETF (PSI), which has risen 18.4% over the past year.
On Jan. 29, Lam Research reported its Q2 earnings, sending shares up 7.4% the next day. The company posted an adjusted EPS of $0.91, beating the analysts' estimate, while revenue reached $4.4 billion, surpassing the consensus. Additionally, Lam's Q3 revenue forecast of $4.7 billion, plus or minus $300 million, exceeded Wall Street's expectations. The company's optimistic outlook, fueled by strong AI-driven demand for advanced chipmaking equipment and high-bandwidth memory (HBM) chips, further boosted investor confidence.
For the current fiscal year, ending in June 2025, analysts expect LRCX’s EPS to grow 24.1% year-over-year to $3.71. The company’s earnings surprise history is promising. It beat the consensus estimate in each of the last four quarters.
Among the 29 analysts covering LRCX stock, the consensus is a “Moderate Buy.” That’s based on 18 “Strong Buy” ratings, two “Moderate Buys,” and nine “Holds.”
This configuration is more bullish than three months ago, with 16 analysts suggesting a “Strong Buy” rating.
On Feb. 20, Mizuho analyst Vijay Rakesh raised Lam Research's price target to $100, maintaining an “Outperform” rating, citing its growing market share in deposition.
As of writing, LRCX is trading below the mean price target of $91.27. The Street-high price target of $110 suggests an ambitious upside potential of 23.6%.
On the date of publication, Rashmi Kumari did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.